54,55 PEA is said to have an entourage effect where it can indirectly increase endocannabinoid receptor activation through various mechanisms such as inhibition of enzymes responsible for degradation of endocannabinoid ligands
520 MorelliLCapursoL
This section explores how parasites alter mitochondrial physiology, focusing on bioenergetic reprogramming, oxidative stress, mitochondrial dynamics, and immune signaling
10.1038/s41467-022-28503-5 64 RewersA.KuppermannN.StonerM
Its easy to see why the addition of PF to bleaching agents has been groundbreaking
Disclosures: Henriette Kreimeyer: Nothing to Disclose, Carlos Gonzalez: Nothing to Disclose, Marcos Fondevila: Nothing to Disclose, Cynthia Hsu: Nothing to Disclose, Phillipp Hartmann: Nothing to Disclose, Xinlian Zhang: Nothing to Disclose, Peter Starkel: Nothing to Disclose, Francisco Bosques: Nothing to Disclose, Elizabeth Verna: Nothing to Disclose, Juan Abraldes: Gilead: Grant/Research Support, 89bio: Consultant, Boston Pharmaceuticals: Consultant, Novo Nordisk: Consultant, Boehringer Ingelheim: Consultant, Astra Zeneca: Consultant, Agomab: Consultant, Terumo: Speaking and Teaching, Cook: Grant/Research Support, Robert Brown: Gilead: Consultant, Intercept: Consultant, Abbvie: Consultant, Madrigal: Consultant, GSK: Consultant, eGenesis: Consultant, mirum: Consultant, Victor Vargas: Ipsen: Advisor, Orphalan: Speaking and Teaching, Jose Altamirano: Nothing to Disclose, Juan Caballeria: Nothing to Disclose, Debbie Shawcross: EnteroBiotix: Consultant, MRM Health: Advisor, Satellite Bio: Consultant, Norgine: Grant/Research Support, Apollo Therapeutics: Consultant, Genfit: Advisor, Alexandre LOUVET: Glaxo-Smith-Kline: Consultant, AbbVie: Speaking and Teaching, Gilead: Speaking and Teaching, Ipsen: Consultant, Astra-Zeneca: Speaking and Teaching, Michael Lucey: Nothing to Disclose, Philippe Mathurin: Nothing to Disclose, Guadalupe Garcia-Tsao: Nothing to Disclose, Ramon Bataller: Nothing to Disclose, Susan Mayo: Nothing to Disclose, David Gonzalez: Nothing to Disclose, Bernd Schnabl: Mabwell Therapeutics: Consultant, Ambys Medicines: Consultant, Surrozen: Consultant, Nterica Bio: Stock privately held company, Axial Biotherapeutics: Grant/Research Support, Prodigy Biotech: Grant/Research Support, CymaBay Therapeutics: Grant/Research Support, Intercept Pharmaceuticals: Grant/Research Support, ChromoLogic: Grant/Research Support 2069 NADH-REDUCTIVE STRESS LINKS THE ANTIOXIDANT CULLIN3-RING E3 LIGASE-NRF2 AXIS TO REGULATION OF HEPATIC STEATOSIS AND INSULIN SENSITIVITY Lijie Gu 1 Yanhong Du 1 Jianglei Chen 1 Mohammad Nazmul Hasan 1 Tiangang Li 1 , 1 University of Oklahoma Health Sciences Center Background Obesity and insulin resistance are major pathogenic drivers of metabolic dysfunction-associated steatotic liver disease (MASLD)
